The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Peripheral blood T-cell receptor repertoire profiling of advanced non-small cell lung cancer patients receiving PD-1/PD-L1 treatment.
 
Diane Tseng
Stock and Other Ownership Interests - Gilead Sciences
Patents, Royalties, Other Intellectual Property - Gilead Sciences
 
Shin-Heng Chiou
Stock and Other Ownership Interests - Arcus Biosciences
Patents, Royalties, Other Intellectual Property - Rutgers Cancer Institute of New Jersey; Stanford University
 
Viswam Nair
Research Funding - Adaptive Biotechnologies
 
Renato G. Martins
Honoraria - Roche/Genentech
Research Funding - Eisai (Inst); Genentech (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)
 
Rafael Santana-Davila
Consulting or Advisory Role - AstraZeneca; EMD Serono; Jazz Pharmaceuticals; Mirati Therapeutics; Takeda Science Foundation
Research Funding - ALX Oncology (Inst); BeyondSpring Pharmaceuticals (Inst); Genentech (Inst); ISA Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
 
Sylvia Lee
Patents, Royalties, Other Intellectual Property - Patent for BRAF-specific TCR, licensed to Lyell Immunopharma.
Travel, Accommodations, Expenses - Iovance Biotherapeutics
 
Keith D. Eaton
Consulting or Advisory Role - Lilly
Research Funding - Mirati Therapeutics (Inst)
 
Christina S Baik
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Daiichi; Guardant Health; Regeneron; Silverback Therapeutics; Takeda; Turning Point Therapeutics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Lilly (Inst); Loxo (Inst); Pfizer (Inst); Rain Therapeutics (Inst); Spectrum Pharmaceuticals (Inst); TP Therapeutics (Inst)
 
A. McGarry Houghton
Consulting or Advisory Role - Johnson & Johnson
Research Funding - Johnson & Johnson